FDA Grants Broadened Indication for Afatinib in First-Line Treatment of Certain Patients with Metastatic NSCLC
ACCC Mourns the Passing of Long-Time Member Marsha Fountain Woznuck, RN, MSN
FDA Approves Denosumab for Prevention of Skeletal-related Events in Multiple Myeloma
CAP Issues Guideline to Ensure Accurate HPV Testing in Head and Neck Cancers
FDA Updates Nilotinib Label to Include Treatment Discontinuation Recommendations for CML with Sustained Molecular Responses
